August 2025

Valneva SE announced that the FDA has removed its recommended pause in the use of IXCHIQ in individuals 60 years of age and older and has approved updates to the Prescribing Information for IXCHIQ.

CorMedix Inc. a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC, a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses announced a definitive agreement for CorMedix to acquire Melinta.

Diploma in Pharmacy of not less than 2 years from a Govt. Organisation or from a Govt. recognized institution.

M.S Pharm, M.Pharm, or Equivalent with specialization in Pharmaceutics, Pharmacology and animal handling from the recognized Board, University, Institute.

Doctoral Degree in Science/ Pharma/ MD/ MS from a recognized University or equivalent. And 2 years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations

BS 4 years programme/BPharm/MBBS/BVSc/Integrated BS- MS/MSc/BE/BTech or equivalent degree, with 55% marks and passing of NET/GATE test

M.Sc. in Biotechnology, Microbiology, Genetics, Biochemistry, Bioinformatics, Food Sciences, Molecular Biology, Genetic Science/ Engg, Botany, Zoology, Life Sciences

Post Graduate Degree in Biochemistry/ Immunology/Microbiology/Clinical Medicine/Life Sciences/Biotechnology/Bio Medical Science / Bioscience.

Post Graduate Degree in Life Science OR Graduate/Post Graduate Degree in associated fields. The ideal candidate should have experience in Cell culture and Imaging. Knowledge of NGS data analysis is an added advantage, but it is not a prerequisite.